French research network for kidney cancer
UroCCR Database: French Research Network for Kidney Cancer (National Multidisciplinary Clinical and Biological Database on Kidney Cancer)
This study is trying to gather detailed information and samples from kidney cancer patients in France to see which surgeries and treatments work best for managing the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 58 sites (Brussels and 57 other locations) |
| Trial ID | NCT03293563 on ClinicalTrials.gov |
What this trial studies
The UroCCR database is a national network in France focused on improving therapeutic management and conducting applied research in kidney cancer. It collects extensive data on patient cases, including over a thousand variables related to disease presentation and evolution, along with biological samples such as plasma, urine, and tumor tissues. This multicentric and multidisciplinary approach aims to evaluate and compare various surgical techniques and drug treatments for kidney cancer, enhancing the understanding of effective management strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients diagnosed with kidney cancer who consent to the collection of their data.
Not a fit: Patients who do not have kidney cancer or those who oppose the collection of their data may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to improved treatment strategies and outcomes for patients with kidney cancer.
How similar studies have performed: Other studies utilizing multicentric and multidisciplinary approaches in cancer research have shown success, indicating a promising potential for this initiative.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient with kidney cancer * Patient with no opposition to collection of its data for the study Exclusion Criteria: none
Where this trial is running
Brussels and 57 other locations
- Hopital Universitaire de Bruxelles — Brussels, Belgium (Not_yet_recruiting)
- CHU Angers — Angers, France (Recruiting)
- CHU Bordeaux — Bordeaux, France (Recruiting)
- Clinique TIVOLI-DUCOS — Bordeaux, France (Recruiting)
- Polyclinique Médipôle Saint-Roch_Cabestany — Cabestany, France (Recruiting)
- CHU Caen — Caen, France (Recruiting)
- CHU de Clermont-Ferrand — Clermont-Ferrand, France (Recruiting)
- Ch Sud Francilien — Corbeil-Essonnes, France (Recruiting)
- CHU Henri Mondor - APHP — Créteil, France (Recruiting)
- CHU de Dijon et CLCC Dijon — Dijon, France (Recruiting)
- CH du Sud Seine et Marne — Fontainebleau, France (Recruiting)
- Centre Hospitalier Départemental de Vendée — La Roche-sur-Yon, France (Not_yet_recruiting)
- CHU Grenoble — La Tronche, France (Recruiting)
- Pôle Santé Sud — Le Mans, France (Recruiting)
- CH Libourne — Libourne, France (Recruiting)
- CHRU Lille - Centre Oscar Lambret — Lille, France (Recruiting)
- Hôpital privé La Louvière — Lille, France (Recruiting)
- CHU Limoges — Limoges, France (Recruiting)
- HCL Lyon — Lyon, France (Recruiting)
- APH Marseille — Marseille, France (Recruiting)
- Institut Paoli-Calmette — Marseille, France (Recruiting)
- Centre Hospitalier d' Annecy Genevois — Metz, France (Not_yet_recruiting)
- CH Mont de Marsan — Mont-de-Marsan, France (Recruiting)
- Clinique du Pont de Chaume — Montauban, France (Recruiting)
- CHRU de Nancy — Nancy, France (Recruiting)
- CHU de Nantes — Nantes, France (Recruiting)
- CHU de Nice — Nice, France (Recruiting)
- Clinique Saint George — Nice, France (Recruiting)
- CHU de Nîmes — Nîmes, France (Recruiting)
- CHU d'Orléans — Orléans, France (Not_yet_recruiting)
- CHU Kremlin Bicêtre - APHP — Paris, France (Recruiting)
- CH St Joseph — Paris, France (Recruiting)
- Hôpital Européen Georges Pompidou - APHP — Paris, France (Recruiting)
- CHU Tenon - APHP — Paris, France (Recruiting)
- Hôpital Bichat -APHP — Paris, France (Recruiting)
- Hôpital Cochin Port-Royal - APHP — Paris, France (Recruiting)
- Hôpital Pitié Salpétrière - APHP — Paris, France (Recruiting)
- Institut Mutualiste Montsouris — Paris, France (Not_yet_recruiting)
- Polyclinique Francheville — Périgueux, France (Recruiting)
- Hôpital privé des Côtes d'Armor — Plérin, France (Recruiting)
- CHU Poitiers — Poitiers, France (Recruiting)
- Hôpital privé Claude Galien — Quincy-sous-Sénart, France (Recruiting)
- Clinique La Croix Du Sud — Quint-Fonsegrives, France (Recruiting)
- CHU Reims — Reims, France (Recruiting)
- CHU Rennes - Centre Eugène Marquis — Rennes, France (Recruiting)
- CHU Rouen — Rouen, France (Recruiting)
- CHU St-Etienne — Saint-Etienne, France (Recruiting)
- Clinique Santé Atlantique de Nantes — Saint-Herblain, France (Recruiting)
- Clinique Urologique Nantes Atlantis — Saint-Herblain, France (Recruiting)
- Clinique Belledonne — Saint-Martin-d'Hères, France (Not_yet_recruiting)
+8 more sites — see ClinicalTrials.gov for the full list.
Study contacts
- Principal investigator: Jean-Christophe BERNHARD, PHU — University Hospital, Bordeaux
- Study coordinator: Jean-Christophe BERNHARD, PHU
- Email: jean-christophe.bernhard@chu-bordeaux.fr
- Phone: +33 (0)5 57 82 03 50
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.